On December 30th Fred Siegman a friend and colleague of many of us who frequent this blog passed away. Fred possessed boundless energy and creativity so work or play was rarely dull when he was around. He was an extremely talented actor and musician and possessed strong business acumen. But of all of his talents, qualities, and skills the ones I value most were his honesty and integrity. I never knew Fred to compromise his values, he stayed the course. He was a friend you could always count on.
Fred you will be missed.
BioBOOM Op/Ed: Dr. Siegman, yes this Ph.D. never throwing his degree around was a leader and pioneer in the Biotech tool industry. He was involved with numerous start ups and handled alot of the day to day dirty work for companies to be successful in the early stages. In the long run he brought untold millions of dollars of value with his small day to day efforts for the industry we know today. Most recently we at BioBOOM were discussing new ideas such as biotech "podcasting" with Fred as the host. God knows how entertaining that would have been. But heaven's gain is our loss. Enjoy Fred. We miss you but know that you made your mark and were called to a higher effort much earlier then we anticipated.
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- Intracellular Observation Of RNA Metabolism Will H...
- Fred Siegman, a friend we will miss
- First Bird Flu Death Confirmed in Iraq
- Germ Sensors
- Bird Flu Gene Analysis Finds New Clue
- Paging Dr. Google
- ABC News: Poll: Most Find Medicare Program Puzzlin...
- Yogurt may help stop HIV infections, report says
- NIH Halts International AIDS Study
- DeCode Genetics Claims Discovery of Major Genetic ...
- Major health emergency' in Calif. from drug plan
- Taiwan breeds transgenic, fluorescent, green pig
- Some Interesting slides from JP Morgan Conference ...
- JPMorgan Healthcare Conference - connect here for ...
- Amylin designing trial of sustained diabetes drug
- Biotech investors swarm into S.F. after encouragin...
- U.S. Farmers to Begin Testing Chickens for Flu
- Hospitals' profit margin hits 6-year high in 2004
- Colon cancer test is promising
- Biotech research has freer hand in Asia
- From Fierce Biotech
- ▼ January (21)